Tithi Roy

Fisetin, a 3,7,3′,4′-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models

Jean Christopher Chamcheu, Stéphane Esnault, Vaqar M. Adhami et al. · Cells · 2019 · 76 citations · Full text

Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation

Tithi Roy, Sergette Banang‐Mbeumi, Samuel Boateng et al. · Frontiers in Immunology · 2023 · 42 citations · Full text

Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers

Tithi Roy, Samuel Boateng, Sergette Banang‐Mbeumi et al. · Bioorganic Chemistry · 2020 · 32 citations · Full text

Medicinal Chemistry, Mtor Inhibitors, Flavonol-based Analogs +8

Synthesis, <i>in silico</i> modelling, and <i>in vitro</i> biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents

Samuel Boateng, Tithi Roy, Kara Torrey et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 20 citations · Full text

Fisetin a 3, 7, 3&amp;prime;, 4&amp;prime;-Tetrahydroxyflavone Inhibits PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models

Jean Christopher Chamcheu, Stéphane Esnault, Vaqar M. Adhami et al. · Preprints.org · 2019 · 19 citations · Full text

Nutraceutical Ingredient, Immunology, Human Skin Model +16